ANI Pharmaceuticals, Inc

(NASDAQ:ANIP)

Latest On ANI Pharmaceuticals, Inc (ANIP):

Date/Time Type Description Signal Details
2023-05-31 02:07 ESTNewsANI Pharmaceuticals: Strong Revenue Growth And ANDA ApprovalsN/A
2023-05-15 20:53 ESTNewsANI Pharma gains as FDA clears generics for Celontin and FosamaxN/A
2023-05-12 20:30 ESTNewsANI Pharmaceuticals down 6%, prices $75M offeringN/A
2023-05-12 06:14 ESTNewsANI Pharmaceuticals announces proposed stock offering, shares fall 6% after hoursN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals soars ~10% after Q1 beat, raises outlook amid rare disease focusN/A
2023-05-08 20:59 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q1 2023 Earnings Call TranscriptN/A
2023-05-08 07:43 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $1.17 beats by $0.82, revenue of $106.79M beats by $23.31MN/A
2023-05-05 23:59 ESTNewsANI Pharmaceuticals Q1 2023 Earnings PreviewN/A
2023-04-24 15:29 ESTNewsANI Pharmaceuticals stock rises after FDA approval of generic antibioticN/A
2023-04-04 10:27 ESTNewsANI Pharma's generic cholesterol-lowering drug gets FDA approvalN/A
2023-03-10 04:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q4 2022 Earnings Call TranscriptN/A
2023-03-09 13:04 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.76 beats by $0.09, revenue of $94.2M beats by $8.06MN/A
2023-03-08 22:19 ESTNewsANI Pharmaceuticals Q4 2022 Earnings PreviewN/A
2023-03-01 22:47 ESTNewsANI Pharma draws Buy at Guggenheim on potential of autoimmune therapyN/A
2023-01-01 20:02 ESTNews2023 A Big Year For Testosterone: AbbVie And ANI Pharmaceuticals Best Positioned To BenefitN/A
2022-12-20 07:38 ESTNewsANI Pharmaceuticals gets FDA approval for generic levocarnitine tabletsN/A
2022-11-16 07:53 ESTNewsANI Pharmaceuticals launches generic antibiotic trimethoprim with FDA approval in bagN/A
2022-11-09 20:16 ESTNewsANI Pharmaceuticals reports Q3 earnings beat; reaffirms FY22 guidanceN/A
2022-11-09 20:14 ESTNewsANI Pharmaceuticals, Inc. (ANIP) Q3 2022 Earnings Call TranscriptN/A
2022-11-09 02:13 ESTNewsANI Pharmaceuticals Q3 2022 Earnings PreviewN/A
2022-09-14 00:52 ESTNewsANI Pharmaceuticals (ANIP) presents at H.C. Wainwright 24th Annual Global Investment Conference - SlideshowN/A
2022-08-30 01:03 ESTNewsANI Pharma launches generic Prochlorperazine maleate tabletsN/A
2022-08-16 21:11 ESTNewsANI Pharmaceuticals' generic dexamethasone tablets get FDA approvalN/A
2022-08-08 18:58 ESTNewsANI Pharmaceuticals Q2 mixed earnings; raises FY 2022 revenue guidance for CortrophinN/A
2022-08-08 18:57 ESTNewsANI Pharma stock rises on Q2 revenue beat, in-line 2022 forecastN/A
2022-08-08 18:57 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-05 14:37 ESTNewsANI Pharmaceuticals Q2 2022 Earnings PreviewN/A
2022-06-22 15:19 ESTNewsANI Pharmaceuticals' generic drug for anxiety disorder gets FDA approvalN/A
2022-06-22 15:18 ESTNewsHot Stocks: WGO rises on earnings, ANIP gains on FDA approval, AVT pops on new partnership, while ORA fallsN/A
2022-06-02 21:40 ESTNewsANI Pharmaceuticals to cease operations at Oakville, Canada manufacturing plantN/A
2022-06-02 03:17 ESTNewsANI Pharma rises after hours on FDA approval for fludrocortisone acetate tabletsN/A
2022-05-10 23:50 ESTNewsANI Pharmaceuticals Non-GAAP EPS of -$0.12 misses by $0.21, revenue of $64.48M misses by $0.55MN/A
2022-05-10 23:49 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-10 01:59 ESTNewsANI Pharmaceuticals Q1 2022 Earnings PreviewN/A
2022-03-15 16:49 ESTNewsANI Pharmaceuticals Non-GAAP EPS of $0.54 misses by $0.20, revenue of $60.9M beats by $4.6MN/A
2022-03-15 16:48 ESTNewsANI Pharma reaches a seven-month low on soft guidance for 2022N/A
2022-03-15 16:47 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-14 23:38 ESTNewsANI Pharmaceuticals Q4 2021 Earnings PreviewN/A
2022-02-09 07:25 ESTNewsANI Pharmaceuticals: Back In The Buy ZoneN/A
2022-01-12 18:27 ESTNewsFTC final order settling antitrust charges clears way for ANI acquisition of NovitiumN/A
2021-12-21 16:27 ESTNewsANI Pharmaceuticals announces FDA approval of Mycobutin genericN/A
2021-11-11 21:20 ESTNewsANI Pharma acquisition of Novitium cleared by FTCN/A
2021-11-11 01:06 ESTNewsANI Pharma, Novitium to divest two generic products as part of mergerN/A
2021-11-04 03:50 ESTNewsANI Pharmaceuticals launches stock offeringN/A
2021-11-01 15:13 ESTNewsFDA grants expanded approval for ANI Pharmaceuticals' Cortrophin GelN/A
2021-11-01 15:13 ESTNewsANI Pharmaceuticals EPS beats by $0.31, beats on revenueN/A
2021-11-01 15:11 ESTNewsANI Pharma surges 44% following strong earnings, expanded approval; hits 52-week highN/A
2021-11-01 15:10 ESTNewsANI Pharmaceuticals, Inc. (ANIP) CEO Nikhil Lalwani on Q3 2021 Results - Earnings Call TranscriptN/A
2021-10-31 19:33 ESTNewsANI Pharmaceuticals Q3 2021 Earnings PreviewN/A
2021-10-02 06:16 ESTNewsANI Pharmaceuticals (ANIP) Investor Presentation - SlideshowN/A

About ANI Pharmaceuticals, Inc (ANIP):

ANI Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract manufacturing for other pharmaceutical companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was founded in 2001 and is headquartered in Baudette, Minnesota.

ANIP Quotes by TradingView

See Advanced Chart

General

  • Name ANI Pharmaceuticals, Inc
  • Symbol ANIP
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 369
  • Last Split Factor1:6
  • Last Split Date2013-07-18
  • Fiscal Year EndDecember
  • IPO Date2000-05-05
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryPharmaceuticals
  • Web URLhttp://www.anipharmaceuticals.com
View More

Valuation

  • Trailing PE 77.58
  • Forward PE 8.31
  • Price/Sales (Trailing 12 Mt.) 1.75
  • Price/Book (Most Recent Quarter) 1.84
  • Enterprise Value Revenue 2.59
  • Enterprise Value EBITDA 19.21
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate $3.44
  • Next Year EPS Estimate $4.43
  • Next Quarter EPS Estimate $0.87
  • Profit Margin -11%
  • Operating Margin -2%
  • Return on Assets -1%
  • Return on Equity -11%
  • Revenue 208.48 million
  • Earnings Per Share $1.34
  • Revenue Per Share $17.43
  • Gross Profit 125.62 million
  • Quarterly Earnings Growth 19.4%
View More

Highlights

  • Market Capitalization 408.05 million
  • EBITDA 39.87 million
  • PE Ratio 55.14
  • PEG Ratio 1.06
  • Analyst Target Price $38.33
  • Book Value Per Share $16.31
View More

Share Statistics

  • Shares Outstanding 12.35 million
  • Shares Float 9.25 million
  • % Held by Insiders 474%
  • % Held by Institutions 79.46%
  • Shares Short 542783
  • Shares Short Prior Month 521318
  • Short Ratio 10.51
  • Short % of Float 7%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.23
  • 52 Week High $52.22
  • 52 Week Low $23.55
  • 50 Day Moving Average 30.62
  • 200 Day Moving Average 29.54
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

ANI Pharmaceuticals, Inc (ANIP) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

ANI Pharmaceuticals, Inc (ANIP) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-09$57.25 million$0.80$0.94-15.19%
2020-09-302020-11-05$52.98 million$0.97$0.889.82%
2020-06-302020-08-06$N/A$0.69$0.75-7.59%
2020-03-312020-05-07$N/A$1.04$0.8916.85%
2019-12-312020-02-27$47.97 million$1.08$1.18-8.73%
2019-09-302019-11-06$51.34 million$1.23$1.43-13.99%
2019-06-302019-08-07$54.36 million$1.44$1.2912.06%
2019-03-312019-05-09$52.89 million$1.30$1.0524.2%
2018-12-312019-02-27$57.12 million$1.32$1.246.45%
2018-09-302018-11-06$50.7 million$1.29$1.1710.26%
2018-06-302018-08-07$47.27 million$1.13$1.34-15.67%
2018-03-312018-05-08$46.48 million$1.32$1.283.53%
2017-12-312018-02-27$47.29 million$1.08$1.053.35%
2017-09-302017-11-02$48.16 million$1.11$0.9912.12%
2017-06-302017-08-03$44.76 million$0.98$0.8613.95%
2017-03-312017-05-04$36.63 million$0.74$0.79-6.33%
2016-12-312017-03-02$38.21 million$0.90$1.10-18.18%
2016-09-302016-11-03$38.53 million$1.09$1.081.24%
2016-06-302016-08-04$31.34 million$1.11$0.7744.16%
2016-03-312016-05-05$20.56 million$0.76$0.708.57%
2015-12-312016-02-23$18.04 million$0.52$0.58-9.57%
2015-09-302015-11-03$19.97 million$0.80$0.5642.86%
2015-06-302015-08-04$19.52 million$0.55$0.541.85%
2015-03-312015-05-05$18.8 million$0.57$0.561.79%
2014-12-312015-02-19$21.04 million$0.42$0.59-28.81%
2014-09-302014-11-03$17.39 million$0.66$0.4643.48%
2014-06-302014-08-04$6.65 million-$0.21-$0.01-2000%
2014-03-312014-05-05$10.9 million$0.33$0.323.13%
2013-12-312014-02-18$15.95 million$0.41$0.2470.83%
2013-09-302013-11-07$7.84 million$0.13
2013-06-302013-08-09$6.15 million-$6.02
2013-03-312013-05-13$145040-$0.56
2012-12-312013-03-01$1.97 million-$1.10
2012-09-302012-11-08$110383-$1.62-$1.8010%
2012-06-302012-08-01$108780-$2.16-$2.4612.2%
2012-03-312012-05-08$114000-$3.24-$1.98-63.64%
2011-12-312012-03-13-$2.16-$4.0546.67%
2011-09-302011-11-09$182784-$4.32-$5.1015.29%
2011-06-302011-07-25$81003-$5.76-$6.4811.11%
2011-03-312011-05-10-$7.20-$5.18-39%
2010-12-312011-03-16-$6.48-$5.31-22.03%
2010-09-302010-11-12-$5.76-$5.04-14.29%
2010-06-302010-08-12-$6.12-$3.78-61.9%
2010-03-312010-05-14-$6.84-$3.78-80.95%
2009-12-312010-03-30-$31.32-$3.96-690.91%
2009-09-302009-11-09-$7.56-$5.76-31.25%
2009-06-302009-08-07-$6.12-$5.40-13.33%
2009-03-312009-05-11-$5.40-$5.766.25%
2008-12-312009-03-16-$1.80-$8.6479.17%
2008-09-302008-11-10-$8.64-$7.20-20%
2008-06-302008-08-11-$7.92-$5.76-37.5%
2008-03-312008-05-09-$4.68-$3.60-30%
2007-12-312008-03-17-$2.16-$2.8825%
2007-09-302007-11-13-$2.16-$3.6941.46%
2007-06-302007-08-14-$3.60-$3.24-11.11%
2007-03-312007-05-01-$2.88-$2.880%
2006-12-312007-03-08$15.84-$2.88650%
2006-09-302006-11-14-$1.08-$4.1473.91%
2006-06-302006-08-14-$3.96-$5.2224.14%
2006-03-312006-05-12-$6.12-$6.485.56%
2005-12-312006-03-31-$4.68-$4.41-6.12%
2005-09-302005-11-10-$3.60-$4.8625.93%
2005-06-302005-08-12-$4.68-$5.4013.33%
2005-03-312005-05-13-$5.04-$5.223.45%
2004-12-312005-02-15-$7.92-$6.30-25.71%
2004-09-302004-11-12-$5.76-$5.760%
2004-06-302004-08-16-$5.55
2004-03-312004-05-17-$6.12-$4.32-41.67%
2003-12-312004-03-09-$3.96
2003-09-302003-11-12-$4.31
2003-06-302003-08-16-$6.41
2003-03-312003-05-15-$4.96
2002-12-312002-12-31-$1.97
2002-09-302002-09-30-$3.91
2002-06-302002-06-30-$7.93
2002-03-312002-03-31-$5.85
2001-12-312001-12-31-$7.84
2001-09-302001-09-30$1.87

ANI Pharmaceuticals, Inc (ANIP) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

ANI Pharmaceuticals, Inc (ANIP) Chart:

ANIP chart by TradingView

ANI Pharmaceuticals, Inc (ANIP) News:

Below you will find a list of latest news for ANI Pharmaceuticals, Inc (ANIP) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

ANI Pharmaceuticals, Inc (ANIP) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2026-05-15400CALL0 0129.92TRUE00
2026-05-15450CALL0 0108.55TRUE00
2026-05-15500CALL0 089.45TRUE00
2026-05-15550CALL0 068.79TRUE00
2026-05-15600CALL0 066.8TRUE00
2026-05-15650CALL0 055.65TRUE00
2026-05-157011.8CALL1 083.13TRUE11.80
2026-05-15750CALL0 250.8TRUE00
2026-05-15803.6CALL1 149.59FALSE3.60
2026-05-15851.9CALL0 567.9FALSE00
2026-05-15901.29CALL1 1054.77FALSE0.070.06
2026-05-15950CALL0 062.18FALSE00
2026-05-151000CALL0 076.23FALSE00
2026-05-151050CALL0 098.28FALSE00
2026-05-151100CALL0 094.55FALSE00
2026-05-15400PUT0 0179.02FALSE00
2026-05-15450PUT0 0153.55FALSE00
2026-05-15500PUT0 0128.95FALSE00
2026-05-15550PUT0 0105.13FALSE00
2026-05-15600PUT0 0108.42FALSE00
2026-05-15650PUT0 089.54FALSE00
2026-05-15700PUT0 067.31FALSE00
2026-05-15750PUT0 151.12FALSE00
2026-05-15800PUT0 057.38TRUE00
2026-05-15850PUT0 055.7TRUE00
2026-05-15900PUT0 056.93TRUE00
2026-05-15950PUT0 056.9TRUE00
2026-05-151000PUT0 046.17TRUE00
2026-05-151050PUT0 060.9TRUE00
2026-05-151100PUT0 060.66TRUE00
2026-06-18400CALL0 00TRUE00
2026-06-18450CALL0 00TRUE00
2026-06-18500CALL0 064.53TRUE00
2026-06-18550CALL0 051.75TRUE00
2026-06-18600CALL0 052.1TRUE00
2026-06-18650CALL0 051.62TRUE00
2026-06-18700CALL0 047.32TRUE00
2026-06-18750CALL0 046.41TRUE00
2026-06-18800CALL0 045.53FALSE00
2026-06-18850CALL0 047.58FALSE00
2026-06-18900CALL0 048.91FALSE00
2026-06-18950CALL0 058.21FALSE00
2026-06-181000CALL0 064.95FALSE00
2026-06-181050CALL0 072.37FALSE00
2026-06-181100CALL0 079.16FALSE00
2026-06-181150CALL0 085.44FALSE00
2026-06-18400PUT0 0150.19FALSE00
2026-06-18450PUT0 0129.11FALSE00
2026-06-18500PUT0 0110.18FALSE00
2026-06-18550PUT0 092.87FALSE00
2026-06-18600PUT0 076.73FALSE00
2026-06-18650PUT0 062.76FALSE00
2026-06-18700PUT0 047.78FALSE00
2026-06-18750PUT0 049.61FALSE00
2026-06-18800PUT0 048.46TRUE00
2026-06-18850PUT0 047.45TRUE00
2026-06-18900PUT0 047.34TRUE00
2026-06-18950PUT0 052.52TRUE00
2026-06-181000PUT0 052.63TRUE00
2026-06-181050PUT0 051.23TRUE00
2026-06-181100PUT0 057.15TRUE00
2026-06-181150PUT0 062.68TRUE00
2026-07-17450CALL0 262.14TRUE00
2026-07-17500CALL0 052.04TRUE00
2026-07-17550CALL0 053.33TRUE00
2026-07-17600CALL0 050.32TRUE00
2026-07-17650CALL0 144.8TRUE00
2026-07-17700CALL0 044.42TRUE00
2026-07-17750CALL0 1144.35TRUE00
2026-07-17800CALL0 2044.07FALSE00
2026-07-17850CALL0 4343.16FALSE00
2026-07-17900CALL0 643.17FALSE00
2026-07-17950CALL0 047.77FALSE00
2026-07-171000CALL0 251.64FALSE00
2026-07-171050CALL0 059.52FALSE00
2026-07-171100CALL0 059.34FALSE00
2026-07-171150CALL0 260.16FALSE00
2026-07-171200CALL0 463.74FALSE00
2026-07-17450PUT0 096.92FALSE00
2026-07-17500PUT0 081.65FALSE00
2026-07-17550PUT0 077.26FALSE00
2026-07-17601.2PUT0 557.28FALSE00
2026-07-17650PUT0 1052.37FALSE00
2026-07-17700PUT0 200344.77FALSE00
2026-07-17750PUT0 1744.5FALSE00
2026-07-17800PUT0 2943.7TRUE00
2026-07-17850PUT0 444.15TRUE00
2026-07-17900PUT0 545.51TRUE00
2026-07-17950PUT0 045.62TRUE00
2026-07-171000PUT0 6049.73TRUE00
2026-07-171050PUT0 144.35TRUE00
2026-07-171100PUT0 046.61TRUE00
2026-07-171150PUT0 051.21TRUE00
2026-07-171200PUT0 054.32TRUE00
2026-10-16400CALL0 060.6TRUE00
2026-10-16450CALL0 057.21TRUE00
2026-10-16500CALL0 050.58TRUE00
2026-10-16550CALL0 149.66TRUE00
2026-10-16600CALL0 348.11TRUE00
2026-10-16650CALL0 245.39TRUE00
2026-10-16700CALL0 245.79TRUE00
2026-10-167512.5CALL2 047.46TRUE12.50
2026-10-16809.65CALL4 444.84FALSE9.650
2026-10-16850CALL0 145.18FALSE00
2026-10-16906.43CALL0 1145.59FALSE00
2026-10-16955CALL0 645.47FALSE00
2026-10-161000CALL0 345.48FALSE00
2026-10-161050CALL0 049.25FALSE00
2026-10-161102.45CALL1 145.73FALSE2.450
2026-10-161150CALL0 049.12FALSE00
2026-10-161201.51CALL0 1238.83FALSE00
2026-10-16400PUT0 077.5FALSE00
2026-10-16450PUT0 072.49FALSE00
2026-10-16501.25PUT0 262.89FALSE00
2026-10-16550PUT0 154.82FALSE00
2026-10-16600PUT0 547.37FALSE00
2026-10-16650PUT0 047.85FALSE00
2026-10-16700PUT0 045.77FALSE00
2026-10-16750PUT0 045.07FALSE00
2026-10-16800PUT0 145.99TRUE00
2026-10-16850PUT0 045.81TRUE00
2026-10-16900PUT0 544.45TRUE00
2026-10-16950PUT0 045.16TRUE00
2026-10-161000PUT0 3545.63TRUE00
2026-10-161050PUT0 045.4TRUE00
2026-10-161100PUT0 046.66TRUE00
2026-10-161150PUT0 046.53TRUE00
2026-10-161200PUT0 045.29TRUE00

Latest ANIP Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST11182$24
Jun 13, 2022 7:58 PM EST140$24
Jun 13, 2022 7:59 PM EST100$24
Jun 13, 2022 7:59 PM EST3$23.98
Jun 13, 2022 7:59 PM EST10$24.005

ANI Pharmaceuticals, Inc (ANIP) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2018-09-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018028121/0000000000-18-028121-index.htm
2018-10-18UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018032671/0000000000-18-032671-index.htm
2018-11-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000018035326/0000000000-18-035326-index.htm
2020-07-14UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1023024/000000000020006407/0000000000-20-006407-index.htm
2019-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000021545719001016/0000215457-19-001016-index.htm
2020-02-04SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1023024/000083423720001478/0000834237-20-001478-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000102302420000008/0001023024-20-000008-index.htm
2019-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919057517/0001104659-19-057517-index.htm
2019-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465919060283/0001104659-19-060283-index.htm
2019-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919060284/0001104659-19-060284-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919067257/0001104659-19-067257-index.htm
2019-12-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919068992/0001104659-19-068992-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465919069229/0001104659-19-069229-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920002449/0001104659-20-002449-index.htm
2020-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920005962/0001104659-20-005962-index.htm
2020-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920023089/0001104659-20-023089-index.htm
2020-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000110465920025744/0001104659-20-025744-index.htm
2020-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920025748/0001104659-20-025748-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041406/0001104659-20-041406-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041409/0001104659-20-041409-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920041411/0001104659-20-041411-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044727/0001104659-20-044727-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044728/0001104659-20-044728-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044729/0001104659-20-044729-index.htm
2020-04-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920044731/0001104659-20-044731-index.htm
2020-04-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046388/0001104659-20-046388-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-04-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-04-23DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049964/0001104659-20-049964-index.htm
2020-04-23DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920049978/0001104659-20-049978-index.htm
2020-04-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920052874/0001104659-20-052874-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920053944/0001104659-20-053944-index.htm
2020-04-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920054478/0001104659-20-054478-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000110465920057791/0001104659-20-057791-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920057797/0001104659-20-057797-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920061654/0001104659-20-061654-index.htm
2020-05-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000110465920064517/0001104659-20-064517-index.htm
2020-06-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920068029/0001104659-20-068029-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920072312/0001104659-20-072312-index.htm
2020-07-09S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1023024/000110465920082375/0001104659-20-082375-index.htm
2020-07-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000110465920084013/0001104659-20-084013-index.htm
2020-08-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920089648/0001104659-20-089648-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091099/0001104659-20-091099-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920091450/0001104659-20-091450-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000110465920121560/0001104659-20-121560-index.htm
2018-05-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030783/0001144204-18-030783-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030785/0001144204-18-030785-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030787/0001144204-18-030787-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418030788/0001144204-18-030788-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418041246/0001144204-18-041246-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042242/0001144204-18-042242-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418042444/0001144204-18-042444-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418042460/0001144204-18-042460-index.htm
2018-09-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2018-09-18CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418049849/0001144204-18-049849-index.htm
2018-10-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418055994/0001144204-18-055994-index.htm
2018-10-31CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1023024/000114420418056446/0001144204-18-056446-index.htm
2018-11-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418057434/0001144204-18-057434-index.htm
2018-11-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420418057627/0001144204-18-057627-index.htm
2018-12-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420418066411/0001144204-18-066411-index.htm
2019-01-025Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419000179/0001144204-19-000179-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419004471/0001144204-19-004471-index.htm
2019-02-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419008991/0001144204-19-008991-index.htm
2019-02-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419010386/0001144204-19-010386-index.htm
2019-02-2710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1023024/000114420419010541/0001144204-19-010541-index.htm
2019-03-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419014333/0001144204-19-014333-index.htm
2019-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017759/0001144204-19-017759-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017765/0001144204-19-017765-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017770/0001144204-19-017770-index.htm
2019-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419017773/0001144204-19-017773-index.htm
2019-04-04DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018181/0001144204-19-018181-index.htm
2019-04-04DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018185/0001144204-19-018185-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018898/0001144204-19-018898-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018899/0001144204-19-018899-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018900/0001144204-19-018900-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419018901/0001144204-19-018901-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020281/0001144204-19-020281-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020282/0001144204-19-020282-index.htm
2019-04-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419020283/0001144204-19-020283-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419023116/0001144204-19-023116-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419024656/0001144204-19-024656-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419024658/0001144204-19-024658-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-05-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419026945/0001144204-19-026945-index.htm
2019-05-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419030641/0001144204-19-030641-index.htm
2019-07-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419036760/0001144204-19-036760-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000114420419038053/0001144204-19-038053-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1023024/000114420419038054/0001144204-19-038054-index.htm
2019-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-234/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000114420419041520/0001144204-19-041520-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002066/0001415889-20-002066-index.htm
2020-08-073Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002067/0001415889-20-002067-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2020-08-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002283/0001415889-20-002283-index.htm
2020-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1023024/000155837020009520/0001558370-20-009520-index.htm
2020-07-17EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1023024/999999999520001852/9999999995-20-001852-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000563/9999999997-19-000563-index.htm
2019-02-22CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719000565/9999999997-19-000565-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719001398/9999999997-19-001398-index.htm
2019-07-01CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999719005909/9999999997-19-005909-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001310/9999999997-20-001310-index.htm
2020-04-02CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001312/9999999997-20-001312-index.htm
2020-04-14CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720001568/9999999997-20-001568-index.htm
2020-05-15CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1023024/999999999720002915/9999999997-20-002915-index.htm

ANI Pharmaceuticals, Inc (ANIP) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of ANI Pharmaceuticals, Inc (ANIP). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 474%
Institutional Ownership: 7946%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-04THOMAS HAUGHEYDirectorBuy3,000.0045.05135,150.0011,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2018-06-06Thomas A. PennDirectorBuy1,200.0012,310.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033527/0001144204-18-033527-index.htm
2020-04-10DAVID NASHDirectorBuy7,119.0012,355.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046396/0001104659-20-046396-index.htm
2020-04-10Patrick D WalshDirectorBuy9,255.0013,046.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046395/0001104659-20-046395-index.htm
2019-03-28Thomas A. PennDirectorBuy1,991.0014,301.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017402/0001144204-19-017402-index.htm
2018-06-06Robert E. JR BrownDirectorBuy1,200.0017,768.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033524/0001144204-18-033524-index.htm
2018-06-06DAVID NASHDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033530/0001144204-18-033530-index.htm
2018-06-06Patrick D WalshDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033532/0001144204-18-033532-index.htm
2018-06-06THOMAS HAUGHEYDirectorBuy1,800.001,800.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418033529/0001144204-18-033529-index.htm
2020-04-10THOMAS HAUGHEYDirectorBuy7,119.0018,410.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046398/0001104659-20-046398-index.htm
2020-05-11Patrick D WalshInterim President and CEOBuy7,050.0020,096.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920060890/0001104659-20-060890-index.htm
2019-05-15ARTHUR PRZYBYLPresident and CEOSell14,633.0069.251,013,335.25202,589.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-03-28Robert E. JR BrownDirectorBuy2,584.0020,352.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017405/0001144204-19-017405-index.htm
2019-03-18ARTHUR PRZYBYLPresident and CEOSell24,802.0063.531,575,671.06205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-03-19ARTHUR PRZYBYLPresident and CEOSell2,823.0063.51179,288.73205,076.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419015117/0001144204-19-015117-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,042.006.366,627.1221,394.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-05-14ARTHUR PRZYBYLPresident and CEOSell5,772.0070.45406,637.40217,222.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-20VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell5,512.0068.18375,808.162,219,259.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-19VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell2,067.0068.30141,176.102,224,771.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040993/0001144204-19-040993-index.htm
2019-08-16VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,349.0068.091,794,103.412,226,838.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-13ARTHUR PRZYBYLPresident and CEOSell9,595.0071.10682,204.50222,994.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026662/0001144204-19-026662-index.htm
2019-08-15VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell9,315.0069.34645,902.102,253,187.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-05-16Robert E. JR BrownDirectorBuy1,167.0033.0038,511.0022,561.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027066/0001144204-19-027066-index.htm
2019-08-14VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell26,360.0069.891,842,300.402,262,502.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419040452/0001144204-19-040452-index.htm
2019-08-13VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell20,821.0071.771,494,323.172,288,862.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.4091,200.0023,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-08-12VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell21,016.0071.451,501,593.202,309,683.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-08-09VENTURE PARTNERS II LP MERIDIAN10% Share HolderSell19,860.0071.701,423,962.002,330,699.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419039648/0001144204-19-039648-index.htm
2019-03-28ARTHUR PRZYBYLPresident and CEOBuy37,280.00242,356.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017410/0001144204-19-017410-index.htm
2019-03-28STEPHEN P. CAREYVice President and CFOBuy12,451.0026,569.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017409/0001144204-19-017409-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy4,000.0030.98123,920.0027,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2020-09-08Nikhil LalwaniPRESIDENT & CEOBuy28,508.0028,508.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002285/0001415889-20-002285-index.htm
2020-04-10Robert E. JR BrownDirectorBuy7,119.0029,680.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046397/0001104659-20-046397-index.htm
2020-08-10Patrick D WalshCHAIRMAN, INTERIM PRES. & CEOBuy3,000.0030.8992,670.0030,096.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002087/0001415889-20-002087-index.htm
2019-03-28DAVID NASHDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017413/0001144204-19-017413-index.htm
2019-03-28Patrick D WalshDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017416/0001144204-19-017416-index.htm
2019-03-28THOMAS HAUGHEYDirectorBuy1,991.003,791.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017408/0001144204-19-017408-index.htm
2018-09-11Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy28,688.006.60189,340.8047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420418049518/0001144204-18-049518-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell5,642.0064.44363,578.3847,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesSell1,503.0064.5096,943.5047,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell4,651.0064.43299,645.7947,842.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy1,503.0033.0049,599.0049,345.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-24DAVID NASHDirectorBuy1,445.0068.7699,358.205,236.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419028634/0001144204-19-028634-index.htm
2019-03-13Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy4,651.0033.00153,483.0052,493.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-03-12Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy5,642.0028.76162,263.9253,484.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419013796/0001144204-19-013796-index.htm
2019-05-13Robert W SchrepferSVP - New Bus Dev & Spec SalesSell2,409.0071.13171,352.1755,927.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419025603/0001144204-19-025603-index.htm
2019-03-28Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy12,451.0060,293.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017403/0001144204-19-017403-index.htm
2019-05-17James G. MarkenSVP Ops & Prod DevSell8,907.0070.67629,457.6961,230.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419027313/0001144204-19-027313-index.htm
2019-05-15THOMAS HAUGHEYDirectorBuy2,500.0069.30173,240.006,291.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026615/0001144204-19-026615-index.htm
2020-04-10STEPHEN P. CAREYVice President and CFOBuy39,767.0063,145.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046394/0001104659-20-046394-index.htm
2019-05-14James G. MarkenSVP Ops & Prod DevSell4,917.0070.31345,714.2770,137.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419026614/0001144204-19-026614-index.htm
2020-08-05Antonio R PeraDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002069/0001415889-20-002069-index.htm
2020-08-05Jeanne ThomaDirectorBuy7,421.007,421.00https://www.sec.gov/Archives/edgar/data/1023024/000141588920002068/0001415889-20-002068-index.htm
2019-03-28James G. MarkenSVP Ops & Prod DevBuy6,848.0075,928.00https://www.sec.gov/Archives/edgar/data/1023024/000114420419017412/0001144204-19-017412-index.htm
2020-03-03THOMAS HAUGHEYDirectorBuy2,000.0045.1890,360.008,291.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920029791/0001104659-20-029791-index.htm
2020-04-10James G. MarkenSVP Ops & Prod DevBuy24,548.0085,297.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046392/0001104659-20-046392-index.htm
2020-04-10Robert W SchrepferSVP - New Bus Dev & Spec SalesBuy39,767.0093,043.00https://www.sec.gov/Archives/edgar/data/1023024/000110465920046393/0001104659-20-046393-index.htm